AstroZhi launches dietary supplement for the treatment of long-term COVID-19 syndrome in the Irish/UK and European markets

April 10, 2024 – (Kilkenny, Ireland) – AstroZhi, a pioneer in scientific research-backed dietary supplements, has announced a breakthrough in healthcare with the launch of a dedicated product designed to aid recovery from long-term COVID-19 syndrome. sexual progress. This highly anticipated move places AstroZhi at the forefront of innovation in the health and wellness space.

AstroZhi’s commitment to advancing the healthcare sector has culminated in the launch of these cutting-edge supplements that promise to revolutionize the landscape of post-COVID health management. The range also includes products designed to relieve anxiety, aid sleep and eliminate harmful parasites.
Commenting on the news, AstroZhi Managing Director Vincent Nolan said: “We are delighted that our formulas are finally easily accessible in Ireland, the UK and Europe. The global health crisis caused by the COVID-19 pandemic Highlighting the urgent need for effective, unbiased solutions to combat the lingering effects of the virus and its associated vaccinations, recent research demonstrates the role of the COVID Spike protein in SARS-CoV-2 infection and vaccination. It persists in the body, is highly toxic and persistent, and is a major driver of long-term COVID-19 syndrome and related immune issues. Our team worked tirelessly to monitor this study, adding nattokinase, bromelain. Powerful compounds like curcumin, considered by top medical experts to be essential in counteracting the effects of spike protein, are an integral part of our formulas and we are excited to announce the launch of our products, now available. Sold across Ireland, the UK and Europe, this marks the beginning of a journey to enhance wellbeing and healing for people around the world.”

The launch of these groundbreaking products marks a transformative milestone in AstroZhi’s mission to contribute to collective efforts aimed at solving the multifaceted challenges posed by COVID-19 and its consequences.

Chief Scientific Officer Raja Subramani said: “As a life sciences company dedicated to advancing human health, we are excited to launch VitaZhi. Each formula is carefully crafted based on reliable scientific research and peer-reviewed clinical data, and draws on cross- Drawing on centuries of traditional knowledge in the field and the latest advances in science, we are committed to harnessing the healing power of natural therapies while adhering to the highest standards of scientific excellence.

With this launch, we are proud to provide innovative solutions to a range of health challenges, including those arising in the wake of COVID-19 infection and vaccination. Our breakthrough products symbolize a new approach to health care, meeting the needs of individuals who cannot find relief through traditional means, and instilling hope and power through the fusion of ancient wisdom and cutting-edge scientific expertise. “

AstroZhi’s breakthrough dietary supplement will have a major impact on the health and wellness sector, bringing hope to those who need professional support to navigate the complexities of post-COVID recovery.